Evidence map›Paper›PMID 26070321›Full record

ArticleJournal of radiation research2015

Mesenchymal stem cell-conditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells.

Yi-Xing Chen, Zhao-Chong Zeng, Jing Sun, Hai-Ying Zeng, Yan- Huang, Zhen-Yu Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Cell Therapies for Acute Radiation Syndrome.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Radiation-induced liver disease: beyond DNA damage.Cell cycle (Georgetown, Tex.) · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yi-Xing ChenDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhao-Chong ZengDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China zeng.zhaochong@zs-hospital.sh.cn.
Jing SunDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Hai-Ying ZengDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yan- HuangDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhen-Yu ZhangDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Fudan University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current management of radiation-induced liver injury is limited. Sinusoidal endothelial cell (SEC) apoptosis and inflammation are considered to be initiating events in hepatic damage. We hypothesized that mesenchymal stem cells (MSCs) possess anti-apoptotic and anti-inflammatory actions during hepatic irradiation, acting via paracrine mechanisms. This study aims to examine whether MSC-derived bioactive components are protective against radiation-induced liver injury in rats. MSC-conditioned medium (MSC-CM) was generated from rat bone marrow-derived MSCs. The effect of MSC-CM on the viability of irradiated SECs was examined by flow cytometric analysis. Activation of the Akt and ERK pathways was analyzed by western blot. MSC-CM was also delivered to Sprague-Dawley rats immediately before receiving liver irradiation, followed by testing for pathological features, changes in serum hyaluronic acid, ALT, and inflammatory cytokine levels, and liver cell apoptosis. MSC-CM enhanced the viability of irradiated SECs in vitro and induced Akt and ERK phosphorylation in these cells. Infusion of MSC-CM immediately before liver irradiation provided a significant anti-apoptotic effect on SECs and improved the histopathological features of injury in the irradiated liver. MSC-CM also reduced the secretion and expression of inflammatory cytokines and increased the expression of anti-inflammatory cytokines. MSC-derived bioactive components could be a novel therapeutic approach for treating radiation-induced liver injury.

Indexed as

AnimalsCells, CulturedDose-Response Relationship, RadiationEndothelial CellsInflammationInflammation MediatorsLiver DiseasesMaleMesenchymal Stem Cell TransplantationRadiation DosageRadiation InjuriesRatsRats, Sprague-DawleyTreatment OutcomeInflammation Mediatorsapoptosismesenchymal stem cellradiation-induced liver injurysinusoidal endothelial cell

Identifiers

PMID26070321
PMCPMC4497399
OpenAlexW2162159612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.